PUBLICACIÓN
Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors
Arlander, E., Ekström, G., Alm, C., Carrillo, J.A., Bielenstein, M., Böttiger, Y., Bertilsson, L., Gustafsson, L.L.
1998 Clinical Pharmacology and Therapeutics
CITAS
74
DOI
10.1016/s0009-9236(98)90131-x
EID
2-s2.0-0031775019
ISSN
0009-9236
BIBTEX
@article{Carrillo Norte1998,title = {Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors},journal = {Clinical Pharmacology and Therapeutics},year = {1998},volume = {64},number = {5},pages = {484-491},author = {Arlander, E. and Ekström, G. and Alm, C. and Carrillo, J.A. and Bielenstein, M. and Böttiger, Y. and Bertilsson, L. and Gustafsson, L.L.}}
AUTORES DE LA UEX